Advanced XLIF Monitoring Pilot Study

December 16, 2025 updated by: NuVasive

Evaluation of Transcutaneous Stimulation of Lumbosacral Nerve Roots: A Pilot Study

Though the utility of NVM5 neuromonitoring by stimulating within the surgical site during XLIF has been demonstrated, it is hypothesized that more information may be gathered if a greater section of the motor neural pathway was monitored (i.e., stimulation above the surgical site and recording the subsequent muscle response in the lower limbs). Currently, there has not been demonstrated a practical method of stimulating the lumbosacral nerve roots locally, but well-above the surgical site in this fashion.

This protocol is intended to evaluate the feasibility and reproducibility of using surface stimulation and return (anode) electrodes to stimulate the lumbosacral nerve roots, and record responses from the relevant innervated muscle groups of the lower limbs.

Study Overview

Status

Completed

Study Type

Observational

Enrollment (Actual)

57

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Colorado
      • Durango, Colorado, United States, 81301
        • Durango Orthopaedics Associates/Spine Colorado
    • Georgia
      • Marrietta, Georgia, United States, 30060
        • Pinnacle Orthopaedics & Sports Medicine Specialists

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Sampling Method

Probability Sample

Study Population

At least 20 subjects will be consecutively enrolled in this prospective pilot study from up to three (3) participating centers. Patients who, in the surgeon investigator's opinion, require lateral approach spinal fusion surgery at spinal level L4-5 (though may include any number of levels from L2 through L5), and have consented to XLIF surgery for their condition will be included. The following eligibility criteria are designed to identify existing clinic patients for whom study under this protocol is considered appropriate. All subjects must meet the inclusion/exclusion criteria below in order to be considered for enrollment.

Description

Inclusion Criteria:

  1. Male and female spine surgery patients who are at least 18 years of age
  2. Surgical candidates for lateral approach lumbar spine surgery at spinal levels L2 to L5, inclusive of L4-5
  3. Patients who understand the conditions of enrollment and are willing to sign an informed consent to participate in the evaluation

Exclusion Criteria:

  1. Currently undergoing surgical treatment at any spinal level other than L2 to L5, including S1
  2. Pregnant women
  3. Implanted pacemaker, defibrillator, or other electronic devices
  4. Involved in active litigation relating to the spine (worker's compensation claim is allowed if it is not contested)
  5. Underlying neurological disease or neurological deficit that is not associated with the condition for which he/she is seeking surgical intervention (e.g., diabetic peripheral neuropathy)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Reproducibility of obtaining reliable responses and response thresholds monitored over the course of surgery.
Time Frame: Intraoperative
Intraoperative

Secondary Outcome Measures

Outcome Measure
Time Frame
Correlation of any observed changes in the response or response thresholds with surgical events.
Time Frame: Intraoperative
Intraoperative
Correlation between patient characteristics and the ability to generate and reliably record responses and response thresholds.
Time Frame: Intraoperative
Intraoperative
Correlation between observed changes in the response or response threshold and postoperative neural status.
Time Frame: 6 weeks postoperative
6 weeks postoperative

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Investigators

  • Study Director: Kyle Malone, MS, NuVasive

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Helpful Links

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

June 1, 2014

Primary Completion (Actual)

May 8, 2018

Study Completion (Actual)

May 8, 2018

Study Registration Dates

First Submitted

July 1, 2014

First Submitted That Met QC Criteria

July 14, 2014

First Posted (Estimated)

July 16, 2014

Study Record Updates

Last Update Posted (Estimated)

December 22, 2025

Last Update Submitted That Met QC Criteria

December 16, 2025

Last Verified

December 1, 2025

More Information

Terms related to this study

Other Study ID Numbers

  • NUVA.NV1301

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Degenerative Lumbar Disc Disease

Subscribe